Type 2 diabetes mellitus The FDA has approved the use of Victoza in patients who have been diagnosed with type 2 diabetes mellitus
Scientific studies often focus on its interaction with neurochemical signaling systems associated with relaxation and restorative biological processes
Utilizing developmentally essential secreted peptides in regenerative medicine
10.1016/j.mce.2008.07.016 [DOI] [PubMed] [Google Scholar] 10.Srinivas-Shankar U, Roberts SA, Connolly MJ, OConnell MD, Adams JE, Oldham JA, Wu FC
revealed that GPX4 overexpression prevents basophilic leukemia cells in mice from death caused by oxidative damage (Imai et al., 1996), thus, theoretically, GPX4 overexpression could make cells resistant to oxidative stress-induced ferroptosis
Integration Of Dual GLP-1/GIP Agonist To Enhance Weight-Loss Efficacy In Obesity Treatment Major companies in the GLP-1 receptor agonist market are focusing on the integration of dual GLP-1/GIP agonist therapies designed to deliver greater weight-loss efficacy and broader metabolic benefits compared to traditional single-pathway treatments
